Previous statins treatment and risk of post-stroke infections;Tratamiento previo con estatinas y riesgo de complicaciones infecciosas tras un infarto cerebral agudo

Neurologia

Volumn 26, Issue 3, 2011, Pages 150-156

  Rodriguez de Antonio L A ^a   Martinez Sanchez P ^a   Martinez Martinez M M ^a   Cazorla Garcia R ^a   Sanz Gallego, I ^a   Fuentes, B ^a   Diez Tejedor E ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Complications; Infections; Statins; Stroke

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PNEUMONIA; PSEUDOMEMBRANOUS COLITIS; RISK FACTOR; SEPSIS; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFECTION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; YOUNG ADULT;

EID: 79952736971     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/j.nrl.2010.07.030     Document Type: Article

References (26)

1. Instituto Nacional de Estadística. Anuario Estadístico de España 2009. Madrid: Instituto Nacional de Estadística; 2009.
2. Aslanyan S., Weir C.J., Diener H.C., Kaste M., Lees K.R. Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol. 2004, 11:49-53.
3. Heuschmann P.U., Kolominsky-Rabas P.L., Misselwitz B., Hermanek P., Leffmann C., Janzen R.W., et al. Predictors of in- hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group. Arch Intern Med. 2004, 164:1761-1768.
4. Hong K.S., Kang D.W., Koo J.S., Yu K.H., Han M.K., Cho Y.J., et al. Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke. Eur J Neurol. 2008, 15:1324-1331.
5. Vermeij F.H., Scholte op Reimer W.J., de Man P., van Oostenbrugge R.J., Franke C.L., de Jong G., et al. Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands stroke survey. Cerebrovasc Dis. 2009, 27:465-471. Netherlands Stroke Survey Investigators, Epub 2009 Mar 28.
6. Sakabe K., Fukuda N., Wakayama K., Nada T., Shinohara H., Tamura Y. Lipid-altering changes and pleiotropic effects of atorvastatin in patients with hipercolesterolemia. Am J Cardiol. 2004, 94:497-500.
7. Terblanche M., Almog Y., Rosenson R.S., Smith T.S., Hackam D.G. Statins and sepsis: multiple modifications at multiple levels. Lancet Infect Dis. 2007, 7:358-368.
8. Rosenson R.S., Tangney C.C., Casey L.C. Inhibition of proinflammatory cytokine production by pravastatin. Lancet. 1999, 353:983-984.
9. Dunzendorfer S., Rothbucher D., Schratzberger P., Reinisch N., Kahler C.M., Wiedermann C.J. Mevalonate-dependent inhibition to transendothelial migration and chemotaxis of human peripheral blood neutrophils by pravastatin. Circ Res. 1997, 81:963-969.
10. Hackman D.G., Mamdani M., Li P., Redelmeier D.A. Statins and sepsis in patients with cardiovascular disease: a population-based cohort analisis. Lancet. 2006, 367:413-418.
11. Gupta R., Platinga L.C., Fink N.E., Melamed M.L., Coresh J., Fox C.S., et al. Statin use and hospitalization for sepsis in patients with chronic kidney disease. JAMA. 2007, 297:1455-1464.
12. Montaner J., Chacón P., Krupinski J., Rubio F., Millán M., Molina C.A., et al. Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial. Eur J Neurol. 2008, 15:82-90.
13. Yoon S.S., Dambrosia J., Chalela J., Ezzeddine M., Warach S., Haymore J., et al. Rising statin use and effect on ischemic stroke outcome. BMC Med. 2004, 2:4.
14. Amarenco P., Bogousslavsky J., Callahan A., Goldstein L.B., Hennerici M., Rudolph A.E., et al. High-dose atorvastatin after stroke or transient ischemic attack. New Engl J Med. 2006, 355:549-559. Stroke Prevention by Aggresive Reduction in Colesterol Levels (SPARCL) Investigators.
15. Arboix A., Álvarez-Sabín J., Soler L. en nombre del Comité de Redacción ad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la SEN, Ictus. Clasificación y criterios diagnósticos. Neurología. 1998, 13(Supl. 3):3-10.
16. Fieschi C., Argentino C., Lenzi G.L., Sacchetti M.L., Toni D., Bozzao L. Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neurol Sci. 1989, 91:311-321.
17. van de Garde E.M., Hak E., Souverein P.C., Hoes A.W., van den Bosch J.M., Leufkens H.G. Statin treatment and reduced risk of pneumonia in patients with diabetes. Thorax. 2006, 61:957-961.
18. Hackam D.G., Mamdani M., Li P., Redelmeier D.A. Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet. 2006, 367:413-418.
19. Kopterides P., Falagas M.E. Statins for sepsis: a critical and updated review. Clin Microbiol Infect. 2009, 15:325-334.
20. Almog Y., Shefer A., Novack V., Maimon N., Barski L., Eizinger M., et al. Prior statin therapy is associated with decreased rate of severe sepsis. Circulation. 2004, 110:880-885.
21. Fernandez R., De Pedro V.J., Artigas A. Statin therapy prior to ICU admisión: protection against infection or a severity marker?. Intensive Care Med. 2006, 160-164.
22. Ovbiagele B., Saber J.L., Starkman S., Kim D., Ali L.K., Jahan R., et al. Statin enhancement of collateralization in acute stroke. Neurology. 2007, 68:2129-2131.
23. Martínez-Sanchez P., Rivera-Ordóñez C., Fuentes B., Ortega-Casarrubios, Idrovo L., Díez-Tejedor E. The benefical effect of statins treatment by stroke subtype. Eur J Neurol. 2009, 16:127-133.
24. Aslayan S., Weir C.J., McIness G.T., Reid J.L., Walter M.R., Lees K.R. Statin administration prior to ischaemic stroke onset and survival: exploratory evidence from matched treatment-control study. Eur J Neurol. 2005, 12:493-498.
25. Martí-Fábregas J., Gomis M., Arboix A., Aleu A., Pagonabarraga J., Belvís R., et al. Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke. 2004, 35:1117-1121.
26. Hinchey J.A., Shephard T., Furie K., Smith D., Wang D., Tonn S. Formal dysphagia screening protocols prevent pneumonia. Stroke. 2005, 36:1972-1976.